1. Home
  2. CLLS vs RMR Comparison

CLLS vs RMR Comparison

Compare CLLS & RMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLLS
  • RMR
  • Stock Information
  • Founded
  • CLLS 1999
  • RMR 1986
  • Country
  • CLLS France
  • RMR United States
  • Employees
  • CLLS N/A
  • RMR N/A
  • Industry
  • CLLS Biotechnology: Pharmaceutical Preparations
  • RMR Professional Services
  • Sector
  • CLLS Health Care
  • RMR Consumer Discretionary
  • Exchange
  • CLLS Nasdaq
  • RMR Nasdaq
  • Market Cap
  • CLLS 299.0M
  • RMR 255.2M
  • IPO Year
  • CLLS 2007
  • RMR N/A
  • Fundamental
  • Price
  • CLLS $3.85
  • RMR $15.61
  • Analyst Decision
  • CLLS Buy
  • RMR
  • Analyst Count
  • CLLS 1
  • RMR 0
  • Target Price
  • CLLS $8.00
  • RMR N/A
  • AVG Volume (30 Days)
  • CLLS 73.5K
  • RMR 182.9K
  • Earning Date
  • CLLS 11-07-2025
  • RMR 11-12-2025
  • Dividend Yield
  • CLLS N/A
  • RMR 11.48%
  • EPS Growth
  • CLLS N/A
  • RMR N/A
  • EPS
  • CLLS N/A
  • RMR 1.03
  • Revenue
  • CLLS $82,551,000.00
  • RMR $196,824,000.00
  • Revenue This Year
  • CLLS N/A
  • RMR $312.10
  • Revenue Next Year
  • CLLS $58.00
  • RMR $1.92
  • P/E Ratio
  • CLLS N/A
  • RMR $15.22
  • Revenue Growth
  • CLLS 129.04
  • RMR N/A
  • 52 Week Low
  • CLLS $1.10
  • RMR $13.48
  • 52 Week High
  • CLLS $5.48
  • RMR $23.10
  • Technical
  • Relative Strength Index (RSI)
  • CLLS 58.54
  • RMR 54.87
  • Support Level
  • CLLS $3.49
  • RMR $15.00
  • Resistance Level
  • CLLS $3.86
  • RMR $16.00
  • Average True Range (ATR)
  • CLLS 0.22
  • RMR 0.54
  • MACD
  • CLLS 0.03
  • RMR 0.08
  • Stochastic Oscillator
  • CLLS 89.76
  • RMR 79.88

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

About RMR The RMR Group Inc.

The RMR Group Inc is a holding company that conducts its business through its subsidiary, which is an alternative asset management company that invests in real estate and manages real estate-related businesses. Its business consists of providing management services to publicly owned real estate investment trusts, or REITs, and real estate-related operating companies. It also provides management services to real estate securities mutual funds and commercial real estate finance companies. The company's operating segment is RMR LLC and All Other Operations. The RMR Group derives its revenue from providing business and property management services as well as advisory and other services.

Share on Social Networks: